ICN Pharmaceuticals Inc. invited Franklin Mutual Advisers, which is part of Franklin Templeton organization, and Iridian Asset Management to submit their candidates for nomination to the board of directors. The two firms indicated they might form a dissident slate of nominees. A new ICN nominating committee, consisting of three independent directors, will review for possible nomination the candidates submitted by Franklin and Iridian, along with those submitted by the board and other shareholders. The annual shareholder meeting is May 29.
ICN Pharmaceuticals Inc. invited Franklin Mutual Advisers, which is...
Sponsored
White Papers
Sponsored Content
Partner Content